IMMUNOLOGIC STUDIES IN PRIMARY BILIARY CIRRHOSIS

原发性胆汁性肝硬化的免疫学研究

基本信息

项目摘要

Abnormal immune mechanisms are being studied in patients with primary biliary cirrhosis (PBC). T cell-mediated help and suppression of pokeweed mitogen-induced immunoglobulin synthesis by B cells have been studied using radioimmunoassays to measure IgG and IgM synthesized by cultures containing appropriate mixtures of different lymphocyte subpopulations in vitro. The ability of T cells to proliferate when cultured with either autologous or allogeneic irradiated B cells (mixed lymphocyte reactions) has been assessed. Results of these studies include the demonstration in PBC of (i) a diminished capacity of T cells to inhibit immunoglobulin synthesis in vitro and (ii) a deficiency of the autologous but not the allogeneic mixed lymphocyte reaction. These findings suggest that in PBC there is a fundamental defect in the interaction between autoreactive T cells and surface antigens on autologous non-T cells which leads to diminished activation of suppressor T cells and hence predisposes to a state of immune hyperresponsiveness. The coexistence of IgA deficiency and PBC has been documented. It is possible that IgA deficiency may contribute to the development of PBC, but the pathogenesis of PBC does not require IgA-dependent mechanisms. Sera from patients with PBC have been shown to contain a factor, probably an abnormally immunoreactive IgM, which blocks the binding of C3b-opsonized erythrocytes by monocytes. This finding affords a potential explanation for the C3b-receptor specific clearance defect by fixed macrophages in PBC. Patients with PBC have been shown to have diminished natural killer cell activity due to a functional defect of cytolytic effector cells. Defects of humoral immunity due to activation of subpopulations of B cells occur in this disease. For example, in PBC there is evidence compatible with the existence of an expanded clone of B cells that synthesize mitochondrial antibodies with different antigenic specificities from those synthesized by normal B cells. A disease-specific immunologic defect has
异常免疫机制正在研究中的患者原发性 胆汁性肝硬化(PBC)。 T细胞介导的美洲商陆的帮助和抑制 已经使用以下方法研究了丝裂原诱导的B细胞的免疫球蛋白合成: 放射免疫测定,以测量由含有以下物质的培养物合成的IgG和IgM 不同淋巴细胞亚群的适当混合物。 的 T细胞在与自体或 同种异体辐照B细胞(混合淋巴细胞反应)已被 评估。 这些研究的结果包括在方案预算委员会中证明: T细胞抑制免疫球蛋白合成的能力减弱, 体外和(ii)缺乏自体但不是同种异体混合 淋巴细胞反应 这些发现表明,在PBC中, 自身反应性T细胞与 自体非T细胞上的表面抗原, 抑制性T细胞的激活,因此易于免疫状态 高反应性 伊加缺乏症与PBC并存, 记录在案。 伊加缺乏症可能有助于 PBC的发展,但PBC的发病机制并不需要 IgA依赖性机制。 PBC患者的血清已被证明 含有一种因子,可能是一种异常免疫反应性IgM, 单核细胞与C3b调理红细胞的结合。 这一发现 为C3b受体特异性清除提供了一种可能的解释 PBC中固定巨噬细胞的缺陷。 PBC患者已被证明 由于功能缺陷, 溶细胞效应细胞。 由于激活的体液免疫缺陷 B细胞的亚群出现在这种疾病中。 例如,在PBC, 这与B细胞的扩增克隆的存在相一致 合成具有不同抗原性的线粒体抗体 与正常B细胞合成的特异性不同。 疾病特异性 免疫缺陷

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

E ANTHONY JONES其他文献

E ANTHONY JONES的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('E ANTHONY JONES', 18)}}的其他基金

STUDIES OF ALPHA-1-ANTITRYPSIN PHENOTYPES AND METABOLISM
ALPHA-1-抗胰蛋白酶表型和代谢的研究
  • 批准号:
    3941102
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
STUDIES RELATING TO THE PATHOGENESIS OF HEPATIC ENCEPHALOPATHY & HEPATIC FAILURE
肝性脑病发病机制的相关研究
  • 批准号:
    3840476
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
IMMUNOLOGIC STUDIES IN PRIMARY BILIARY CIRRHOSIS
原发性胆汁性肝硬化的免疫学研究
  • 批准号:
    3918248
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
IMMUNOLOGIC STUDIES IN PRIMARY BILIARY CIRRHOSIS
原发性胆汁性肝硬化的免疫学研究
  • 批准号:
    3855405
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
IMMUNOLOGIC STUDIES IN PRIMARY BILIARY CIRRHOSIS
原发性胆汁性肝硬化的免疫学研究
  • 批准号:
    4690017
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
STUDIES OF HEPATIC RECEPTORS FOR GLYCOPROTEINS
肝糖蛋白受体的研究
  • 批准号:
    4690019
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
STUDIES OF RELATING TO THE PATHOGENESIS OF HEPATIC ENCEPHALOPATHY
肝性脑病发病机制的相关研究
  • 批准号:
    3918247
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
IMMUNOLOGIC STUDIES IN PRIMARY BILIARY CIRRHOSIS
原发性胆汁性肝硬化的免疫学研究
  • 批准号:
    3840477
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
STUDIES OF HEPATIC RECEPTORS FOR GLYCOPROTEINS
肝糖蛋白受体的研究
  • 批准号:
    3964819
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
STUDIES OF ALPHA-1-ANTITRYPSIN PHENOTYPES
ALPHA-1-抗胰蛋白酶表型的研究
  • 批准号:
    4690018
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:

相似海外基金

Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    RGPIN-2019-06980
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
  • 批准号:
    10581488
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574979-2022
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
  • 批准号:
    10332251
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574984-2022
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574985-2022
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574978-2022
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
  • 批准号:
    444149
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
    Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
  • 批准号:
    RGPIN-2015-05491
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
    Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
  • 批准号:
    RGPIN-2019-06980
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了